| An essential role for LEDGF/p75 in HIV integration M Llano, DT Saenz, A Meehan, P Wongthida, M Peretz, WH Walker, ... Science 314 (5798), 461-464, 2006 | 679 | 2006 |
| Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus RM Diaz, F Galivo, T Kottke, P Wongthida, J Qiao, J Thompson, M Valdes, ... Cancer research 67 (6), 2840-2848, 2007 | 342 | 2007 |
| Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy J Qiao, T Kottke, C Willmon, F Galivo, P Wongthida, RM Diaz, J Thompson, ... Nature medicine 14 (1), 37-44, 2008 | 188 | 2008 |
| Expression of IFN-β enhances both efficacy and safety of oncolytic vesicular stomatitis virus for therapy of mesothelioma CL Willmon, V Saloura, ZG Fridlender, P Wongthida, RM Diaz, ... Cancer research 69 (19), 7713-7720, 2009 | 130 | 2009 |
| Type III IFN interleukin-28 mediates the antitumor efficacy of oncolytic virus VSV in immune-competent mouse models of cancer P Wongthida, RM Diaz, F Galivo, T Kottke, J Thompson, J Pulido, ... Cancer research 70 (11), 4539-4549, 2010 | 124 | 2010 |
| Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma J Pulido, T Kottke, J Thompson, F Galivo, P Wongthida, RM Diaz, ... Nature biotechnology 30 (4), 337-343, 2012 | 118 | 2012 |
| Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virus F Galivo, RM Diaz, U Thanarajasingam, D Jevremovic, P Wongthida, ... Human gene therapy 21 (4), 439-450, 2010 | 102 | 2010 |
| Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors T Kottke, F Errington, J Pulido, F Galivo, J Thompson, P Wongthida, ... Nature medicine 17 (7), 854-859, 2011 | 100 | 2011 |
| Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma F Galivo, RM Diaz, P Wongthida, J Thompson, T Kottke, G Barber, ... Gene therapy 17 (2), 158-170, 2010 | 92 | 2010 |
| Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virus P Wongthida, RM Diaz, C Pulido, D Rommelfanger, F Galivo, K Kaluza, ... Human gene therapy 22 (11), 1343-1353, 2011 | 90 | 2011 |
| VSV oncolytic virotherapy in the B16 model depends upon intact MyD88 signaling P Wongthida, RM Diaz, F Galivo, T Kottke, J Thompson, A Melcher, R Vile Molecular Therapy 19 (1), 150-158, 2011 | 82 | 2011 |
| Treg depletion–enhanced IL-2 treatment facilitates therapy of established tumors using systemically delivered Oncolytic virus T Kottke, F Galivo, P Wongthida, RM Diaz, J Thompson, D Jevremovic, ... Molecular therapy 16 (7), 1217-1226, 2008 | 77 | 2008 |
| Oncolytic virus-derived type I interferon restricts CAR T cell therapy L Evgin, AL Huff, P Wongthida, J Thompson, T Kottke, J Tonne, ... Nature communications 11 (1), 3187, 2020 | 73 | 2020 |
| Use of biological therapy to enhance both virotherapy and adoptive T-cell therapy for cancer T Kottke, RM Diaz, K Kaluza, J Pulido, F Galivo, P Wongthida, ... Molecular therapy 16 (12), 1910-1918, 2008 | 69 | 2008 |
| Genetic manipulation of porcine epidemic diarrhoea virus recovered from a full-length infectious cDNA clone J Jengarn, P Wongthida, N Wanasen, PN Frantz, A Wanitchang, ... Journal of General Virology 96 (8), 2206-2218, 2015 | 64 | 2015 |
| Systemic combination virotherapy for melanoma with tumor antigen-expressing vesicular stomatitis virus and adoptive T-cell transfer DM Rommelfanger, P Wongthida, RM Diaz, KM Kaluza, JM Thompson, ... Cancer research 72 (18), 4753-4764, 2012 | 63 | 2012 |
| Vesicular stomatitis virus-induced immune suppressor cells generate antagonism between intratumoral oncolytic virus and cyclophosphamide C Willmon, RM Diaz, P Wongthida, F Galivo, T Kottke, J Thompson, ... Molecular Therapy 19 (1), 140-149, 2011 | 59 | 2011 |
| APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy CB Driscoll, MR Schuelke, T Kottke, JM Thompson, P Wongthida, ... Nature communications 11 (1), 790, 2020 | 55 | 2020 |
| Ad5NULL-A20: A Tropism-Modified, αvβ6 Integrin-Selective Oncolytic Adenovirus for Epithelial Ovarian Cancer Therapies H Uusi-Kerttula, JA Davies, JM Thompson, P Wongthida, L Evgin, ... Clinical Cancer Research 24 (17), 4215-4224, 2018 | 43 | 2018 |
| Deciphering the biology of porcine epidemic diarrhea virus in the era of reverse genetics S Teeravechyan, PN Frantz, P Wongthida, T Chailangkarn, ... Virus research 226, 152-171, 2016 | 29 | 2016 |
